(Q40423412)

English

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

West Nile virus

0 references

Canarypox virus

object named as

canarypox virus

1 reference

based on heuristic

inferred from title

author name string

H El Garch

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

J M Minke

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

J Rehder

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

S Richard

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

C Edlund Toulemonde

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

S Dinic

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

C Andreoni

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

J C Audonnet

8

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

R Nordgren

9

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

V Juillard

10

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Veterinary Immunology and Immunopathology

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

123

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3-4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

230-239

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Innate sensing of viruses by toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Use of recombinant modified vaccinia Ankara viral vectors for equine influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Current perspectives on control of equine influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Innate and Adaptive Immune Responses Determine Protection against Disseminated Infection by West Nile Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

West Nile virus: a growing concern?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

An improved plasmid DNA expression vector for direct injection into skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis factor alpha secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Dendritic cells and NK cells stimulate bystander T cell activation in response to TLR agonists through secretion of IFN-alpha beta and IFN-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Efficacy of a canarypox virus-vectored vaccine against feline leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Recombinant canarypox vaccine-elicited CTL specific for dominant and subdominant simian immunodeficiency virus epitopes in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Role of CD8+ T cells in control of West Nile virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

CD8+ T Cells Require Perforin To Clear West Nile Virus from Infected Neurons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.02.002

7 January 2021

Identifiers

10.1016/J.VETIMM.2008.02.002

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40423412&oldid=1897349662"